logo
Swiss Firms Balance Data Laws, Microsoft Cloud Initiatives

Swiss Firms Balance Data Laws, Microsoft Cloud Initiatives

Yahoo14-05-2025
Service providers help companies pursue AI adoption while complying with complex data protection rules, ISG Provider Lens™ report says
ZÜRICH, May 14, 2025--(BUSINESS WIRE)--Enterprises in Switzerland are integrating Microsoft cloud platforms while navigating strict privacy and data sovereignty regulations, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm.
The 2025 ISG Provider Lens™ Microsoft AI and Cloud Ecosystem report for Switzerland finds that many companies in Switzerland, one of the world's most loyal Microsoft markets, are deeply committed to Azure, Microsoft 365 and other platforms. However, they are also subject to complex data protection regulations, especially in sectors such as finance and healthcare.
"Data sovereignty and privacy are major concerns for Swiss enterprises," said Uwe Ladwig, managing director, ISG Switzerland. "Microsoft's data centers in Zurich and Geneva allow companies to store data in the country, but maintaining trust also requires tight operational control. A carefully chosen service provider can help clients develop a comprehensive data protection plan."
Many Swiss companies see emerging cloud and AI technologies as critical to remaining competitive, but implementing a wide range of Microsoft offerings can overwhelm internal teams, resulting in governance gaps, ISG says. Enterprises are seeking qualified providers to align new technology initiatives with local mandates such as the Swiss Federal Act on Data Protection.
Companies in Switzerland, like those in Germany, are embracing Microsoft's Copilot generative AI chatbot and Azure OpenAI Services, ISG says. They look to GenAI to accelerate automation and innovation and seek immediate productivity gains through improved efficiency, though many have struggled to achieve meaningful results so far. Service providers with extensive experience and use-case libraries are proving essential to success in this area.
Interest in AI agents within Microsoft 365 is also growing, though most companies exploring this area are at an early stage and lack clear use cases, ISG says. Not all providers in Switzerland are yet prepared to support the use of these agents by their clients.
Demand is rising in Switzerland for Microsoft's Fabric, Foundry and Purview platforms, which enterprises are deploying together to create integrated data environments with high security and efficient data utilization, ISG says. The platforms are designed to substantially reduce regulatory risk, a key consideration for many of the country's enterprises.
"Swiss companies face competing pressures to innovate while complying with increasingly complex regulations," said Jan Erik Aase, partner and global leader, ISG Provider Lens Research. "They are partnering with leading local and global service providers to develop balanced strategies and execute on them."
The report also explores other Microsoft ecosystem trends affecting enterprises in Switzerland, including growing enterprise interest in multi-cloud and hybrid cloud environments and Microsoft's increasing investments in data center infrastructure.
For more insights into the Microsoft-related challenges faced by enterprises in Switzerland, plus ISG's advice for addressing them, see the ISG Provider Lens™ Focal Points briefing here.
The 2025 ISG Provider Lens™ Microsoft AI and Cloud Ecosystem report for Switzerland evaluates the capabilities of 42 providers across four quadrants: Managed Services for Azure, Microsoft 365 Services, Power Platform Services and AI Services for the Microsoft Clouds.
The report names Swisscom as a Leader in all four quadrants. It names ELCA/EveryWare and SoftwareOne as Leaders in three quadrants each. Ambit Group, Atos, Aveniq, Bechtle, BitHawk, Data One, isolutions, MDW Group, T-Systems and Wipro are named as Leaders in two quadrants each. Accenture & Avanade, adesso, DIGITALL, Kyndryl, PwC, TCS and UMB are named as Leaders in one quadrant each.
In addition, glueckkanja is named as a Rising Star — a company with a "promising portfolio" and "high future potential" by ISG's definition — in two quadrants. BitHawk and Kyndryl are named as Rising Stars in one quadrant each.
In the area of customer experience, HCLTech is named the global ISG CX Star Performer for 2025 among Microsoft ecosystem providers. HCLTech earned the highest customer satisfaction scores in ISG's Voice of the Customer survey, part of the ISG Star of Excellence™ program, the premier quality recognition for the technology and business services industry.
Customized versions of the report are available from BitHawk and glueckkanja.
The 2025 ISG Provider Lens™ Microsoft AI and Cloud Ecosystem report for Switzerland is available to subscribers or for one-time purchase on this webpage.
About ISG Provider Lens™ Research
The ISG Provider Lens™ Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Canada, Mexico, Brazil, the U.K., France, Benelux, Germany, Switzerland, the Nordics, Australia and Singapore/Malaysia, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage.
About ISG
ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world's top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250514018124/en/
Contacts
Philipp Jaensch, ISG+49 151 730 365 76philipp.jaensch@isg-one.com
Matthias Longo, for ISG+49 152 341 464 63matthias@longo-pr.de
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Merging deep tech and biomedical science expertise, ChronicleBio aims to accelerate breakthroughs for millions living with complex chronic conditions
Merging deep tech and biomedical science expertise, ChronicleBio aims to accelerate breakthroughs for millions living with complex chronic conditions

Yahoo

time23 minutes ago

  • Yahoo

Merging deep tech and biomedical science expertise, ChronicleBio aims to accelerate breakthroughs for millions living with complex chronic conditions

New venture harnesses multi-omic data and AI to develop the largest platform on complex chronic illnesses to drive breakthroughs in POTS, ME/CFS, Long COVID, and other neuroimmune disorders SAN FRANCISCO, Aug. 5, 2025 /PRNewswire/ -- ChronicleBio, a techbio startup focused on radically accelerating insights on neuroimmune disorders, officially launched Tuesday with a bold mission: to build the world's richest, AI-ready data platform for historically overlooked conditions like POTS, ME/CFS, Long COVID, and other complex chronic conditions. ChronicleBio is uniquely led by a founding team that unites elite tech, healthcare, and life sciences: Fidji Simo (Co-founder), current CEO of Instacart and the incoming CEO of OpenAI's applications division, brings deep expertise in consumer-scale technology, product innovation, and health systems transformation. Rohit Gupta (Co-founder & CEO), a biobanking and precision medicine leader who previously oversaw centers at Stanford and UCSF, is the leading scientific and strategic force behind ChronicleBio. Rishi Reddy (Co-founder & Executive Chairman), of Tarsadia Investments, brings an entrepreneurial and venture-backed perspective and a track record in health and life sciences investing. Together, they are tackling a critical gap in biomedical research. ChronicleBio is creating a scalable, ethically driven data ecosystem, integrating clinical, molecular, biospecimen, and patient-reported insights to drive biomarker discovery, patient stratification, and precision therapeutic development. "Entire communities of patients have been ignored for too long, not because their conditions aren't debilitating and prevalent, but because the systems weren't built to understand them," said Fidji Simo, co-founder of ChronicleBio. "ChronicleBio is developing a future where patients can enlist in research, and where the data we collect from them goes directly towards better diagnostics and therapeutics. By building these critical missing datasets and leveraging the massive advances in AI, we aim to accelerate the path to cures." These complex chronic conditions impact nearly 300 million people worldwide, but remain woefully understudied, leaving patients hopeless and without meaningful treatments. It's a disease space desperate for data, and ChronicleBio is offering the scalable solutions to provide it. "Neuroimmune disorders remain some of the most poorly understood in medicine and not for lack of interest, but because the underlying data simply doesn't exist at the scale or structure required for serious breakthroughs," said Rohit Gupta, co-founder and CEO of ChronicleBio. "We're empowering patients and clinicians to get involved in this effort to grow our research-grade biobank and AI-ready data platform so we can close that gap and provide the tools to finally interrogate these diseases with scientific rigor and precision, bringing an end to complex chronic conditions." ChronicleBio partners directly with patients, clinics, and research collaborators to generate longitudinal, multi-modal datasets, including genomics, immune profiling, and real-world outcomes designed for exploration and clinical trial readiness. Its platform is already being used in multiple high-integrity clinics in the U.S. and India, as well as through research collaborations with thousands of patients contributing data and biosamples. "We're creating an ecosystem with global reach, designed not just to generate data, but to fundamentally shift how we discover, develop, and deliver treatments at scale. The opportunity for impact—scientifically, medically, and societally—is enormous," said Rishi Reddy, co-founder and Executive Chairman of ChronicleBio. "We're building the foundational infrastructure for a massive medical need that has been hiding in plain sight." ChronicleBio's founding vision isn't just ambitious. It's personal. Both Simo and Reddy have been diagnosed with at least one of the very conditions the company is focused on researching. Gupta's family also suffers from neuroimmune disorders. The group's world-class expertise is outshined only by its heartfelt determination to rewrite the scientific narrative for the millions of patients overlooked by traditional research and transform lived experience into actionable discovery. ChronicleBio's approach includes: A global biobank platform collecting and connecting data on neuroimmune illnesses A proprietary, AI-ready data engine designed to integrate multi-omic, clinical, and real-world evidence Strategic partnerships with clinics, research consortia, and biotech sponsors looking to unlock hard-to-crack therapeutic areas A decentralized clinical trial network accelerating drug development through real-world access to patients and clinicians For more information, visit or follow ChronicleBio on LinkedIn, X, Instagram, and Facebook. Media Contact:media@ View original content to download multimedia: SOURCE ChronicleBio Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Shopify Q2 Preview: Tariff Noise and GMV Leverage in Focus
Shopify Q2 Preview: Tariff Noise and GMV Leverage in Focus

Yahoo

time23 minutes ago

  • Yahoo

Shopify Q2 Preview: Tariff Noise and GMV Leverage in Focus

Shopify (NASDAQ:SHOP) reports second-quarter 2025 earnings before the open on August 6. Analysts forecast EPS of $0.29 on approximately $2.54 billion in revenue, about 25% YoY growth. Shares are up roughly 92% over the past 12 months and 9% below its 52-week high hit in February 2025. Investor focus remains on GMV, monetization, and merchant exposure to trade friction. Last quarter, total GMV grew 23% to $75 billion. Analysts will look for continued momentum in platform sales, take?rate stability, and revenue per merchant, particularly within Merchant Solutions, where margins are more exposed to cross-border trade costs. Tariffs have become a merchant-level risk. Shopify executives highlighted at Q1 earnings that just 1% of GMV originates from Chinese imports, but cross-border commerce contributed 15% of total GMV. The elimination of the U.S. de minimis exemption for China means merchants now face duties on low-value imports. Shopify has responded with AI-powered tariff guidance tools and expanded duties?collection functionality at checkout to help merchants mitigate cost exposure and friction. AI and international merchant expansion also matter. Shopify continues to roll out AI tools to drive merchant efficiency and boost international cross-border sales. Investors will assess whether Q2 commentary confirms traction in these segments, especially Europe, Managed Markets, and new logistics partnerships, all critical to sustaining profitability as trade friction rises. At a valuation pricing in robust growth, Shopify needs Q2 commentary that reaffirms GMV momentum, merchant loyalty, and the value of its trade?navigation toolkit. Any sign of softening volume or take?rate pressure could signal vulnerability. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Jim Cramer Notes 'CoreWeave Was Good'
Jim Cramer Notes 'CoreWeave Was Good'

Yahoo

time23 minutes ago

  • Yahoo

Jim Cramer Notes 'CoreWeave Was Good'

CoreWeave, Inc. (NASDAQ:CRWV) is one of the stocks that Jim Cramer spoke about. Answering a caller's query about the company during the lightning round, Cramer said: 'Look, I think CoreWeave, I gotta tell you, CoreWeave was up 11 today, CoreWeave was 11. I think CoreWeave was good. Remember, NVIDIA's better than CoreWeave. I think CoreWeave might even tell you that.' Photo by Chris Liverani on Unsplash CoreWeave (NASDAQ:CRWV) provides a cloud platform optimized for GenAI workloads, as it provides compute, storage, networking, and managed services. The company's tools support AI model training, inference, rendering, and dataset optimization for enterprise-scale deployments. When a caller inquired about the stock during the July 21 episode, he responded: 'Alright, I think I like CoreWeave and I like Michael Intrator, but I would say the stock is $60 billion, and it's going to have to come down and cool off a little bit. There are too many shorts in it. The shorts are covering right now. Once they're finished covering, I think the stock does drop, and you can take a look at it.' While we acknowledge the potential of CRWV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store